Literature DB >> 25038562

Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses.

Nina Daschil1, Christian Humpel2.   

Abstract

Neurodegeneration of cholinergic and dopaminergic neurons is a major hallmark in Alzheimer's or Parkinson's disease, respectively. A dysregulation in calcium homeostasis may be part of this process and counteracting calcium influx may have neuroprotective properties in both diseases. Therefore, we investigated the putative neuroprotective or neurotoxic activity of L-type calcium channel (LTCC) inhibitors on cholinergic and dopaminergic neurons in a rat organotypic vibrosection model. Sagittal or coronal vibrosections (200 μm thick) of postnatal day 10 rats were cultured on 0.4 μm semipermeable membranes for 2 weeks with 10 ng/ml nerve growth factor (NGF) and/or glial-cell line derived neurotrophic factor (GDNF) to maintain survival of cholinergic or dopaminergic neurons, respectively. Thereafter, sections were incubated with 0.1, 1 or 10 μM isradipine, nicardipine or verapamil for 2 weeks to explore cytotoxicity. Alternatively, in order to explore neuroprotective activity, vibrosections were incubated without growth factors but with isradipine or verapamil or with nicardipine, nimodipine or nifedipine from the beginning for 4 weeks. Our data show that all LTCC inhibitors exhibited no neurotoxic effect on cholinergic and dopaminergic neurons. Further, LTCC inhibitors did not have any neuroprotective activity on cholinergic neurons. However, nimodipine and nifedipine significantly enhanced the survival of dopaminergic substantia nigra (SN) but not ventral tegmental area (VTA) neurons, while nicardipine, isradipine and verapamil had no effect. Nifedipine (and more potently GDNF) reduced inflammatory cytokines (macrophage inflammatory protein-2, tumor necrosis factor-α), but did not influence oxidative stress or caspase-3 activity and did not interfere with iron-mediated overload. Our data show that nifedipine and nimodipine are very potent to enhance the survival of axotomized SN neurons, possibly influencing inflammatory processes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer׳s disease; Calcium; L-type calcium channel inhibitor; Neuroprotection; Neurotoxicity; Parkinson׳s disease

Mesh:

Substances:

Year:  2014        PMID: 25038562      PMCID: PMC4337977          DOI: 10.1016/j.brainres.2014.07.014

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

1.  3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices.

Authors:  D S Schatz; W A Kaufmann; R Schuligoi; C Humpel; A Saria
Journal:  Synapse       Date:  2000-04       Impact factor: 2.562

2.  A simple method for organotypic cultures of nervous tissue.

Authors:  L Stoppini; P A Buchs; D Muller
Journal:  J Neurosci Methods       Date:  1991-04       Impact factor: 2.390

3.  Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.

Authors:  Yachen Li; Xiaoming Hu; Yuxin Liu; Yongming Bao; Lijia An
Journal:  Neuropharmacology       Date:  2008-11-21       Impact factor: 5.250

Review 4.  Organotypic slice cultures: a technique has come of age.

Authors:  B H Gähwiler; M Capogna; D Debanne; R A McKinney; S M Thompson
Journal:  Trends Neurosci       Date:  1997-10       Impact factor: 13.837

5.  Continuous presence of nerve growth factor is required for maintenance of cholinergic septal neurons in organotypic slice cultures.

Authors:  B H Gähwiler; L Rietschin; T Knöpfel; A Enz
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

6.  Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert.

Authors:  C Weis; J Marksteiner; C Humpel
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

7.  Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices. Implication in Alzheimer's disease?

Authors:  C Humpel; C Weis
Journal:  J Neural Transm Suppl       Date:  2002

Review 8.  Calcium homeostasis, selective vulnerability and Parkinson's disease.

Authors:  C Savio Chan; Tracy S Gertler; D James Surmeier
Journal:  Trends Neurosci       Date:  2009-03-21       Impact factor: 13.837

9.  Role of voltage-gated L-type Ca2+ channel isoforms for brain function.

Authors:  J Striessnig; A Koschak; M J Sinnegger-Brauns; A Hetzenauer; N K Nguyen; P Busquet; G Pelster; N Singewald
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

10.  Dopamine Release Suppression Dependent on an Increase of Intracellular Ca(2+) Contributed to Rotenone-induced Neurotoxicity in PC12 Cells.

Authors:  Yan Sai; Junfeng Chen; Feng Ye; Yuanpeng Zhao; Zhongmin Zou; Jia Cao; Zhaojun Dong
Journal:  J Toxicol Pathol       Date:  2013-07-10       Impact factor: 1.628

View more
  10 in total

1.  Projection length stimulated by oxytocin is modulated by the inhibition of calcium signaling in U-87MG cells.

Authors:  M Zatkova; Z Bacova; F Puerta; Z Lestanova; M Alanazi; A Kiss; A Reichova; A M Castejon; D Ostatnikova; Jan Bakos
Journal:  J Neural Transm (Vienna)       Date:  2018-09-29       Impact factor: 3.575

2.  Neurite Outgrowth Stimulated by Oxytocin Is Modulated by Inhibition of the Calcium Voltage-Gated Channels.

Authors:  M Zatkova; A Reichova; Z Bacova; V Strbak; A Kiss; J Bakos
Journal:  Cell Mol Neurobiol       Date:  2017-05-10       Impact factor: 5.046

3.  Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease.

Authors:  Katerina D Oikonomou; Elissa J Donzis; Minh T N Bui; Carlos Cepeda; Michael S Levine
Journal:  J Neurophysiol       Date:  2021-09-01       Impact factor: 2.974

4.  Neuroprotective Effects of Telmisartan and Nifedipine Against Cuprizone-Induced Demyelination and Behavioral Dysfunction in Mice: Roles of NF-κB and Nrf2.

Authors:  Amira E Abd El Aziz; Rabab Hamed Sayed; Nada A Sallam; Nesrine S El Sayed
Journal:  Inflammation       Date:  2021-03-11       Impact factor: 4.092

5.  Nimodipine but Not Nifedipine Promotes Expression of Fatty Acid 2-Hydroxylase in a Surgical Stress Model Based on Neuro2a Cells.

Authors:  Eva Herzfeld; Lea Speh; Christian Strauss; Christian Scheller
Journal:  Int J Mol Sci       Date:  2017-05-03       Impact factor: 5.923

Review 6.  Nimodipine Reappraised: An Old Drug With a Future.

Authors:  Andrew P Carlson; Daniel Hänggi; Robert L Macdonald; Claude W Shuttleworth
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

7.  Develop a 3D neurological disease model of human cortical glutamatergic neurons using micropillar-based scaffolds.

Authors:  Cheng Chen; Xin Dong; Kai-Heng Fang; Fang Yuan; Yao Hu; Min Xu; Yu Huang; Xixiang Zhang; Danjun Fang; Yan Liu
Journal:  Acta Pharm Sin B       Date:  2019-03-23       Impact factor: 11.413

Review 8.  The Use of ex Vivo Rodent Platforms in Neuroscience Translational Research With Attention to the 3Rs Philosophy.

Authors:  Laura Lossi; Adalberto Merighi
Journal:  Front Vet Sci       Date:  2018-07-19

9.  Nimodipine Reduces Dysfunction and Demyelination in Models of Multiple Sclerosis.

Authors:  Roshni A Desai; Andrew L Davies; Natalie Del Rossi; Mohamed Tachrount; Alex Dyson; Britta Gustavson; Pardis Kaynezhad; Lewis Mackenzie; Marieke A van der Putten; Daniel McElroy; Dimitra Schiza; Christopher Linington; Mervyn Singer; Andrew R Harvey; Ilias Tachtsidis; Xavier Golay; Kenneth J Smith
Journal:  Ann Neurol       Date:  2020-05-06       Impact factor: 10.422

10.  Nimodipine Exerts Time-Dependent Neuroprotective Effect after Excitotoxical Damage in Organotypic Slice Cultures.

Authors:  Urszula Hohmann; Chalid Ghadban; Tim Hohmann; Joshua Kleine; Miriam Schmidt; Christian Scheller; Christian Strauss; Faramarz Dehghani
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.